RNS Number : 1560V
Bion PLC
12 April 2021
 

12 April 2021

 

BiON plc

("BiON" or "the Company")

 

Appointment of Joint Broker

 

BiON (AIM: BION), an environmental engineering, wastewater treatment and renewable energy solutions company, is pleased to announce the appointment of VSA Capital Limited as Joint Broker with immediate effect.

 

As a specialised investment banking and corporate broking firm, VSA Capital will be responsible for providing research, advising the Company on the development of its activities in the renewable energy space internationally and communicating with, and broadening, the Company's shareholder base.  

 

Datuk Syed Nazim bin Syed Faisal, CEO of BiON, said: "The appointment of VSA Capital as Joint Broker marks a further step in our journey as we seek to accelerate our growth strategy to become an international renewable energy company."

 

 

Enquiries:

 

BiON plc


Datuk Syed Nazim bin Syed Faisal, CEO 

Fakrizzaki Ghazali, CFO

+603 6413 1085

Elle Sia, UK Country Manager

www.bionplc.com

+44 20 3633 0891



Beaumont Cornish Limited (Nominated Adviser)


Roland Cornish, Felicity Geidt    

+44 20 7628 3396



VSA Capital Limited (Joint Broker)


Andrew Raca, Maciek Szymanski, Vivian Papasotiriou (Corporate Finance)

+44 20 3005 5000

Andrew Monk (Corporate Broking)




Optiva Securities Limited (Joint Broker)


Vishal Balasingham

+44 20 3137 1903



Luther Pendragon (Financial PR Adviser)


Claire Norbury

+44 20 7618 9100

 

 

 

                                                                                               

 

                                                                                                                               

 

                                                                                                                                               

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPBGGDSXDBDGBD